Nucleolar MED19 regulates 2′-O-methylation of rRNA in supporting cancer cell growth
Nucleic Acids Research · 26.11.2025 · 53 (22)
DOI: 10.1093/nar/gkaf1387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.12.2025. Verfasst von Yang Ming und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Zhongshan Hospital, Fudan University, Shanghai 20…. Hauptthemen laut MEDLINE: RNA, Ribosomal, Cell Nucleolus, Mediator Complex, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology, State Key Laboratory of Genetics and Development of Complex Phenotypes.
Abstract (Originalsprache)
The Mediator complex is a transcriptional co-factor for RNA polymerase II (Pol II)-dependent gene expression, with MED19 serving as an integral subunit. While MED19 overexpression has been documented in diverse cancer types to promote tumor progression, the underlying molecular mechanisms remain poorly understood. Here, we uncover a previously unrecognized function whereby MED19 localizes to the nucleolus independently of the Mediator complex. This nucleolar targeting is mediated by a conserved poly-lysine motif at the MED19 C-terminus, which enables binding to ribosomal RNA (rRNA) and fibrillarin (FBL), a catalytic component of the 2′-O-methyltransferase complex and pre-rRNA processing factor. Mechanistically, MED19 facilitates rRNA processing and 2′-O-methylation that promotes the efficiency of internal ribosome entry site-dependent translation for a number of onco-promoting genes including c-Myc. Collectively, these findings reveal a novel Mediator-independent function of MED19 in regulating ribosome-mediated translational control, thus providing mechanistic insights into its onco-promoting role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Zhongshan Hospital, Fudan University, Shanghai 200438, China.
- School of Biological Sciences, Faculty of Science, The University of Hong Kong, Hong Kong999077, China.
- State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, School of Life Sciences, Inner Mongolia University, Hohhot010021, China.
- Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou 310000, China.
ORCID-Profile: Gang Wang
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology
- State Key Laboratory of Genetics and Development of Complex Phenotypes
Zitieren
APA
Ming, Y., Jiamin, Z., Yu, P., Chengjiang, L., Yiyang, Z., Hanqing, Z., Zhou, Q., & Wang, G. (2025). Nucleolar MED19 regulates 2′-O-methylation of rRNA in supporting cancer cell growth. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1387
Vancouver
Ming Y, Jiamin Z, Yu P, Chengjiang L, Yiyang Z, Hanqing Z, et al. Nucleolar MED19 regulates 2′-O-methylation of rRNA in supporting cancer cell growth. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1387
BibTeX
@article{Ming2025,
author = {Ming, Yang and Jiamin, Zhao and Yu, Peng and Chengjiang, Lu and Yiyang, Zhang and Hanqing, Zhang and Zhou, Qiang and Wang, Gang},
title = {Nucleolar MED19 regulates 2′-O-methylation of rRNA in supporting cancer cell growth},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {22},
doi = {10.1093/nar/gkaf1387}
}
EUVIMED